Attention Deficit Hyperactivity Disorder: Developing Stimulant Drugs for Treatment Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 6, 2019
April 11, 2024
0fcd99c6-644f-41df-81ff-6f0bd09628b2
Related Documents
Stimulant Use Disorders: Developing Drugs for Treatment
Guidance DocumentOctober 5, 2023Center for Drug Evaluation and Research
Nonalcoholic Steatohepatitis with Compensated Cirrhosis: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentJune 7, 2019Center for Drug Evaluation and Research
Major Depressive Disorder: Developing Drugs for Treatment
Guidance DocumentJune 21, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox